UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 07,
iBio (AMEX:IBIO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more iBio Charts.
iBio (AMEX:IBIO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more iBio Charts.

Ibio, Inc. News

iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.
iBio Announces $15.0 Million Private Placement
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.
Form 8-K - Current report
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
Monday 26 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)
iBio Announces Participation in 23rd Annual PepTalk Conference
Tuesday 16 January 2024 (4 months ago) • GlobeNewswire Inc.
Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 26 December 2023 (4 months ago) • Edgar (US Regulatory)
iBio Amends and Extends Maturity of Credit Agreement
Tuesday 26 December 2023 (4 months ago) • GlobeNewswire Inc.

More Ibio, Inc. News Articles